Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting

Dranitsaris George; Gluck Stefan; Faria Claudio; Cox David; Rugo Hope

首页> 外文期刊>Clinical therapeutics >Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting

【24h】

Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting

机译：社区环境中三联阴性转移性乳腺癌细胞毒药物单一疗法的比较疗效分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose: There has been considerable progress in the treatment of metastatic breast cancer. However, the identification of optimal cytotoxic agents in patients with triple-negative breast cancer (TNBC) (negative for hormone receptors and human epidermal growth factor receptor 2) remains a therapeutic challenge. We conducted a comparative effectiveness analysis of 4 cytotoxic agents in patients with TNBC.

机译：目的：在转移性乳腺癌的治疗中取得了长足的进步。然而，在三阴性乳腺癌（TNBC）（激素受体和人表皮生长因子受体2阴性）患者中确定最佳的细胞毒剂仍然是治疗上的挑战。我们对TNBC患者中的4种细胞毒性药物进行了比较有效性分析。

著录项

来源
《Clinical therapeutics》 |2015年第1期|共11页
作者
Dranitsaris George; Gluck Stefan; Faria Claudio; Cox David; Rugo Hope;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
eribulin; capecitabine; gemcitabine; metastatic breast cancer; triple negative; vinorelbine;

机译：eribulin;卡培他滨;吉西他滨;转移性乳腺癌;三阴性;长春瑞滨;

相似文献

外文文献
中文文献
专利

1. Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting [J] . Dranitsaris George, Gluck Stefan, Faria Claudio, Clinical therapeutics . 2015,第1期

机译：社区环境中三联阴性转移性乳腺癌细胞毒药物单一疗法的比较疗效分析
2. Comparative effectiveness of everolimus-based therapy versus endocrine monotherapy among postmenopausal women with HR+/HER2-metastatic breast cancer: a retrospective chart review in community oncology practices in the US [J] . Xie Jipan, Hao Yanni, Li Nanxin, Current medical research and opinion . 2015,第6期

机译：依维莫司治疗与内分泌单一治疗在HR + / HER2转移性乳腺癌绝经后妇女中的比较有效性：美国社区肿瘤学实践的回顾性图表回顾
3. Comparative effectiveness of first-line nab-paclitaxel versus paclitaxel monotherapy in triple-negative breast cancer [J] . Luhn Patricia, Chui Stephen Y., Hsieh Fu-Chi, Journal of comparative effectiveness research . 2019,第14期

机译：一线Nab-PACLITAXEL对三重阴性乳腺癌紫杉醇单疗法的比较效果
4. Simulating an Immune Response with a Combined Agent-Based Model of a Triple-Negative Breast Cancer Tumor and Vascular Network [C] . Michael Ventoso, Kerri-Ann Norton IEEE International Conference on Bioinformatics and Biomedicine . 2020

机译：用三重阴性乳腺癌肿瘤和血管网络的基于组合药物的免疫应答模拟免疫应答
5. Preclinical exploration of novel small molecules as anticancer agents in triple-negative and HER2/neu-positive breast cancers. [D] . Weng, Shu-Chuan. 2008

机译：在三阴性和HER2 / neu阳性乳腺癌中作为抗癌药的新型小分子的临床前探索。
6. Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis [O] . Reshma L Mahtani, Monika Parisi, Stefan Glück, 2018

机译：早期nab-紫杉醇与紫杉醇在转移性乳腺癌患者中的比较有效性：基于美国社区的现实世界分析
7. PCN14 Comparative effectiveness of everolimus vs. fulvestrant monotherapy among postmenopausal women with hr+/her2- metastatic breast cancer [O] . Lin P.L., Hao Y., Xie J., 2015

机译：PCN14依维莫司与氟维司群单药治疗在具有hr + / her2转移性乳腺癌的绝经后妇女中的比较有效性
8. Novel Differentiation Therapy Approach to Reduce the Metastatic Potential of Basal, Highly Metastatic, Triple-Negative Breast Cancers. [R] . Chu, I. 2012

机译：新型分化治疗方法降低基底，高转移性，三阴性乳腺癌的转移潜能。

Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅